In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Critical issues in antithrombotic therapy
Session

Event : ESC Congress 2016

Topic : Hypertension – Treatment

  • Session type : Meet the Experts
  • Date : 27 August 2016
  • Time : 13:30 - 15:00

8 presentations in this session

Critical issues in antithrombotic therapy - Introduction to the session

Event : ESC Congress 2016

  • Session : Critical issues in antithrombotic therapy
  • Speaker : S Agewall (Oslo,NO)

A patient with atrial fibrillation and stenting for stable angina

Event : ESC Congress 2016

  • Session : Critical issues in antithrombotic therapy
  • Speaker : R Dalmau (Madrid,ES)

A patient with acute coronary syndrome developing atrial fibrillation

Event : ESC Congress 2016

  • Session : Critical issues in antithrombotic therapy
  • Speaker : T Hall (Oslo,NO)

A patient with acute coronary syndrome and diabetes: duration of DAPT

Event : ESC Congress 2016

  • Session : Critical issues in antithrombotic therapy
  • Speaker : J Poess (Luebeck,DE)

Critical issues in antithrombotic therapy - Take home message

Event : ESC Congress 2016

  • Session : Critical issues in antithrombotic therapy
  • Speaker : GMC Rosano (London,GB)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are